Zydus signs MoU with Apollo Hospitals to expand access to the ShieldTM Multi-Cancer Detection test (MCD) in India

Bengaluru : Zydus Lifesciences Ltd. (Zydus), an innovation driven global lifesciences company and Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, have an exclusive agreement to make the ShieldTM Multi-Cancer Detection (MCD) test available in India, for which Zydus has signed a Memorandum of Understanding (MoU) with Apollo Hospitals to offer the test...